Isotechnika Pharma Inc IPHAF

RE: RE: RE: Re: NR today

[macbethorfaust]

Effectively we have sold the diagnostics tool.   Difficult to assess the price but even though it is not a huge money maker (and lets face it none of us are here because of the diagnostics tool) off the top it looks like a pretty good price for Palladin (and otherwise they would not have done the deal).  So think of it as expensive but non-dilutive financing at a time when funds are tight.

So, like the last deal, not something we would have done in the normal course but pretty good given the cards we are playing with.  It will be interesting to see the burn rate when the next M & A come out.  I think an additional $1.65M will buy us a fair bit of time.

Does reinforce my view though that Palladin will try and take us out before we reach a buck.